Select Country

 
877-783-6728 (877-StemSave)

StemSave Blog

A Sight for Sore Eyes – Stem Cells Discovered on Surface of Retina.

Posted by devin@stemsave.com on Dec 2, 2014 5:45:49 AM

Scientists may one day be able to treat AMD with stem cells from the retina.

A team of researchers led by Professor Andrew Lotery at Southampton General Hospital have discovered a source of retinal stem cells on the surface of the eye. If scientists can harvest these readily accessible stem cells, convert them to light-sensitive cells, and then transplant them back into the eye, the cells could provide new treatments for age-related macular degeneration [AMD].

Read More

Topics: neural stem cells, Eye, stemsaveblog, dry age-related macular degeneration, Debilitating Diseases, Stemcells, autologousstemcells, Blindness

Blindness Treatment Utilizes Stem Cells to Partially Restore Vision.

Posted by anna@stemsave.com on Mar 14, 2014 11:07:59 AM

The use of adult stem cells can potentially treat a wide range of visual impairments.

Researchers from the Institute for Ophthalmology at the University College of London report on a significant advancement in stem cell therapy that can potentially lead to new treatments for blindness. Adult stem cells were manipulated into rod cells and then injected into blind animal models, partially restoring the vision of the animals.

Read More

Topics: Eye, stemsaveblog, aging, clinical trials, dry age-related macular degeneration, Debilitating Diseases, Stemcells, Blindness

Age-Related Macular Degeneration Treatment Utilizes Stem Cells

Posted by devin@stemsave.com on Feb 15, 2014 11:19:18 AM

Stem Cell implants could replace damaged cells affected by AMD.

Collaborating reseachers from the Department of Ophthalmology at the Bonn University Hospital and the Neural Stem Cell Institute in New York have successfully replaced damaged cells in eyes impaired by Age-Related Macular Degeneration (AMD) with human stem cells. This implantation technique, conducted in an animal study is the first of its kind and represents a significant advance in developing personalized treatments for patients suffering from a variety of age-related visual impairment issues.

Read More

Topics: Eye, stemsaveblog, aging, dry age-related macular degeneration, Stemcells, autologousstemcells, Blindness

Novel Use of Stem Cells Advance Treatment Options for Macular Degeneration

Posted by taylor@stemsave.com on Dec 19, 2012 5:00:25 AM

Researchers at University of Wisconsin’s McPherson Eye Research Institute are utilizing stem cells to develop a patient-specific model of a rare form of macular degeneration - Best Disease. The model has led researchers to a better understanding of the cellular processes that cause the disease which should lead to the development of more effective treatment options.

Read More

Topics: Eye, stemsaveblog, dry age-related macular degeneration, Stemcells, autologousstemcells, Best Disease

Stem Cell Treatment for Dry Age-Related Macular Degeneration Entering Clinical Trial Phase

Posted by Kelsey StemSave on Nov 9, 2012 5:00:16 AM

 

 

 

 

 

A Phase I/II clinical trial to treat dry age-related macular degeneration (Dry-AMD) is being conducted by StemCells, Inc. Dry-AMD is the most common type of macular degeneration and affects 90% of patients with the condition. It is a chronic eye disease that causes vision loss in the center of the field of vision and is the major cause of blindness and visual impairment in adults older than 50.

Read More

Topics: Phase III, neural stem cells, stemsaveblog, clinical trials, dry age-related macular degeneration, Stemcells, Phase I/II clinical trials, clinical trial, Dry AMD, StemCells Inc., AMD

Stem Cell Treatment for Dry Age-Related Macular Degeneration Entering Clinical Trial Phase

Posted by Kelsey StemSave on Nov 9, 2012 5:00:16 AM

 

 

 

 

 

A Phase I/II clinical trial to treat dry age-related macular degeneration (Dry-AMD) is being conducted by StemCells, Inc. Dry-AMD is the most common type of macular degeneration and affects 90% of patients with the condition. It is a chronic eye disease that causes vision loss in the center of the field of vision and is the major cause of blindness and visual impairment in adults older than 50.

Read More

Topics: Phase III, stemsaveblog, clinical trials, dry age-related macular degeneration, Stemcells

AAOMS

AAOMS - American Association of Oral and Maxillofacial Surgeons

 

As the industry leader, StemSave is the only stem cell banking service to be designated as an ASI approved program.

Subscribe to Email Updates

Join our Newsletter

Posts by Topic

see all